EXEVATE-MF OINTMENT 0.05 % W/W + 3.0 % W/W + 10.0 % W/W + 3.0 % W/W + 2.0 % W/W TOPICAL EXTERNAL OINTMENTS Uganda - English - National Drug Authority

exevate-mf ointment 0.05 % w/w + 3.0 % w/w + 10.0 % w/w + 3.0 % w/w + 2.0 % w/w topical external ointments

ochoa laboratories limited - - betamethasone dipropionate + salicylic acid + urea + lactic acid + sodium lactate solution - topical external ointments - 0.05 % w/w + 3.0 % w/w + 10.0 % w/w + 3.0 % w/w + 2.0 % w/w

DIPROSONE betamethasone 0.5 mg/g (as dipropionate) cream tube Australia - English - Department of Health (Therapeutic Goods Administration)

diprosone betamethasone 0.5 mg/g (as dipropionate) cream tube

organon pharma pty ltd - betamethasone dipropionate, quantity: 0.64 mg/g (equivalent: betamethasone, qty 0.5 mg/g) - cream - excipient ingredients: liquid paraffin; monobasic sodium phosphate dihydrate; phosphoric acid; white soft paraffin; cetomacrogol 1000; cetostearyl alcohol; sodium hydroxide; chlorocresol; purified water - indications as at 22 november 1995: diprosone is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. these include atopic eczema, infantile eczema, nummular eczema, contact dermatitis, neurodermatitis, anogenital and senile pruritus, lichen planus, intertrigo and psoriasis.

DIPROSALIC 0.05/3 Base %w/w Ointment Ireland - English - HPRA (Health Products Regulatory Authority)

diprosalic 0.05/3 base %w/w ointment

b & s healthcare - betamethasone dipropionate, salicylic acid - ointment - 0.05/3 base %w/w - corticosteroids, potent, other combinations

DiproSalic 0.05% w/w + 2% w/w Scalp Application Ireland - English - HPRA (Health Products Regulatory Authority)

diprosalic 0.05% w/w + 2% w/w scalp application

merck sharp & dohme ireland (human health) limited - betamethasone dipropionate; salicylic acid - cutaneous solution - 0.05 %w/w+2 percent weight/weight - corticosteroids, potent, other combinations; betamethasone

Diprosalic 0.05%/3% ointment United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

diprosalic 0.05%/3% ointment

organon pharma (uk) ltd - betamethasone dipropionate; salicylic acid - cutaneous ointment - 500microgram/1gram ; 30mg/1gram

BEPROSALIC LOTION Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

beprosalic lotion

hoe pharmaceuticals sdn. bhd. - betamethasone dipropionate; salicylic acid/2-hydroxybenzoic acid -

DiproSalic 0.05% w/w + 2% w/w scalp application Ireland - English - HPRA (Health Products Regulatory Authority)

diprosalic 0.05% w/w + 2% w/w scalp application

organon pharma (ireland) limited - betamethasone dipropionate; salicylic acid - cutaneous solution - 0.05 %w/w+2 percent weight/weight - corticosteroids, potent, other combinations; betamethasone

DiproSalic 0.05% w/w + 2% w/w scalp application Ireland - English - HPRA (Health Products Regulatory Authority)

diprosalic 0.05% w/w + 2% w/w scalp application

imed healthcare ltd. - betamethasone dipropionate; salicylic acid - cutaneous solution - corticosteroids, potent, other combinations; betamethasone

DIPROSONE betamethasone 0.5 mg/g (as dipropionate) ointment tube Australia - English - Department of Health (Therapeutic Goods Administration)

diprosone betamethasone 0.5 mg/g (as dipropionate) ointment tube

organon pharma pty ltd - betamethasone dipropionate, quantity: 0.64 mg/g (equivalent: betamethasone, qty 0.5 mg/g) - ointment - excipient ingredients: white soft paraffin; liquid paraffin - indications as at 22 november 1995: diprosone is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. these include atopic eczema, infantile eczema, nummular eczema, contact dermatitis, neurodermatitis, anogenital and senile pruritus, lichen planus, intertrigo and psoriasis.

DIPROSALIC OINTMENT Israel - English - Ministry of Health

diprosalic ointment

organon pharma israel ltd., israel - betamethasone as dipropionate; salicylic acid - ointment - salicylic acid 30 mg/g; betamethasone as dipropionate 0.5 mg/g - betamethasone - betamethasone - provides anti inflammatory, antipruritic, anti allergic and chronic hyperkeratotic and dry keratolytic activity in the topical management of subacute dermatoses responsive to corticosteroid therapy.